Upper Respiratory Tract Symptoms, Renal Involvement and Vasculitis: A Case Report and Review of Wegener Granulomatosis
暂无分享,去创建一个
[1] Richard W. Lee,et al. Novel Therapies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis , 2012, Drugs.
[2] U. Demkow,et al. Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary Wegener's granulomatosis. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[3] E. Jwarah,et al. Wegener's granulomatosis in pregnancy , 2006, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[4] P. Lamprecht,et al. Maintenance of remission with leflunomide in Wegener's granulomatosis. , 2003, Rheumatology.
[5] R. Waldherr,et al. Expression of cytokines and growth factors in human glomerulonephritides , 1993, Pediatric Nephrology.
[6] C. Savage,et al. Mechanisms of endothelial cell injury in vasculitis , 2004, Springer Seminars in Immunopathology.
[7] J. Stone,et al. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety. , 2001, Arthritis and rheumatism.
[8] L. Bostad,et al. Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] C. Kallenberg,et al. Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis , 2001, Current opinion in nephrology and hypertension.
[10] P. Limburg,et al. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. , 2000, Arthritis and rheumatism.
[11] C. Langford,et al. Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis. , 2000, Arthritis and rheumatism.
[12] C. Langford,et al. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance. , 1999, Arthritis and rheumatism.
[13] C. Kallenberg,et al. Monocyte activation in patients with Wegener’s granulomatosis , 1999, Annals of the rheumatic diseases.
[14] M. Haubitz,et al. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. , 1998, Arthritis and rheumatism.
[15] B. Hoen,et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. , 1997, Arthritis and rheumatism.
[16] R. Kimberly,et al. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. , 1994, Journal of immunology.
[17] A. Borne,et al. Relevance of classic anti‐neutrophil cytoplasmic autoantibody (C‐ANCA)‐mediated inhibition of proteinase 3‐α1‐antitrypsin complexation to disease activity in Wegener's granulomatosis , 1993, Clinical and experimental immunology.
[18] A. Rees,et al. HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. , 1992, Kidney international.
[19] F. Ognibene,et al. Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis. , 1991, The American review of respiratory disease.
[20] V. A. Lisovskii,et al. [Wegener's granulomatosis]. , 1972, Klinicheskaia meditsina.